PDGF receptor kinase inhibitors (AEterna Zentaris)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePDGF receptor kinase inhibitors (AEterna Zentaris)
Drug Alias NamePDGF receptor kinase inhibitors (Zentaris)Bis(1H-2-indolyl)methanone derivatives (ASTA Medica)PDGF receptor kinase inhibitors (ASTA Medica)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsFibrosisAtherosclerosisVascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsta Medica Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsta Medica AgCOSCIENS Biopharma Inc
Active IndicationsN/A
Inactive IndicationsFibrosisAtherosclerosisVascular Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A